The Likely Next Legalized Recreational Drug in the US: Psilocybin Mushrooms
Drug legalization in the United States has been gaining momentum in recent years. While cannabis remains the primary focus, the next likely candidate to be legalized for wider use could be psilocybin mushrooms. This article explores why psilocybin mushrooms may be the next step, how other drugs are likely to be reclassified, and the broader context of drug policy reform in the US.What is Psilocybin and Its Current Legal Status
Psilocybin, the key psychoactive compound found in certain types of mushrooms, has a long history of use across different cultures. To date, the recreational use of psilocybin is by no means legal in most of the United States. However, several states, including Denver, Colorado, have taken steps to decriminalize it.Psilocybin Mushrooms: A Step in Recreational Drug Legalization
For recreational purposes, psilocybin mushrooms have a strong candidate profile. They are not only considered the least dangerous of all recreational drugs but also offer potential therapeutic benefits. A study by the National Institute on Drug Abuse (NIDA) ranked Psilocybin as the third least harmful drug, below alcohol and tobacco.However, it’s not just the recreational use that makes psilocybin a target for legalization. Research into its medical applications is already underway. Psilocybin has been shown to be beneficial in treating conditions like depression, anxiety, and post-traumatic stress disorder (PTSD). These findings suggest that legalization could accelerate these medical breakthroughs.
Other Likely Candidates for Legalization
Cannabis is undoubtedly a frontrunner, having already been legalized in several states for medical and recreational use. However, the next likely candidates are MDMA (Ecstasy) and kratom, both of which have been decriminalized or have had their legal status rescinded by state and federal authorities.MDMA: MDMA, similar to psilocybin, shows promise in treating PTSD and other psychiatric disorders. The drug has been shown in clinical trials to be safe and effective when used under controlled conditions. The potential for MDMA to treat trauma and anxiety could lead to its reclassification from Schedule I to a more manageable category.
Kratom: Despite its controversial history, kratom is increasingly being reviewed for its medical benefits. Once banned by the FDA, it has been rescinded in most states. This plant-based compound has been shown to alleviate chronic pain and anxiety, making it a potential candidate for medical legalization.
Drug Policy Reform and the Future
The current drug policy in the United States has largely been deemed a failure. Critics argue that the zero-tolerance approach has not solved the drug problem but has instead exacerbated the issue. The next steps in drug policy reform will likely involve comprehensive legalization and regulation, similar to the success seen in states like Colorado and Washington with marijuana legalization.The decriminalization of psilocybin mushrooms in Denver and the broader trend towards legalization suggest that we are moving towards a new era of drug policy. This shift is driven not only by public opinion but also by increasing evidence of the therapeutic benefits of certain drugs. The next steps for nationwide reform are clear:
States leading the way will continue to take individual actions, such as decriminalization and medical legalization. The federal government will likely follow, with increased research and regulation. The public and policymakers will play crucial roles in advocating for and supporting these changes.